The prevalence of hyperkalemia in the United States

References

• Dunn JD, Benton WW, Orozco-Torrentera E, Adamson RT. The burden of hyperkalemia in patients with cardiovascular and renal disease. Am J Manag Care 2015;21(15Suppl):S307–S15
   Web of Science ®Google Scholar
• Jain N, Kotla S, Little BB, et al. Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am J Cardiol 2012;109:1510–13
   PubMed Web of Science ®Google Scholar
• Goyal A, Spertus JA, Gosch K, et al. Serum potassium levels and mortality in acute myocardial infarction. JAMA 2012;307:157–64
   PubMed Web of Science ®Google Scholar
• An JN, Lee JP, Jeon HJ, et al. Severe hyperkalemia requiring hospitalization: predictors of mortality. Crit Care 2012;16:R225
   PubMed Web of Science ®Google Scholar
• Nyirenda MJ, Tang JI, Padfield PL, Seckl JR. Hyperkalaemia. BMJ 2009;339:b4114
   PubMed Web of Science ®Google Scholar
• Weir MR, Rolfe M. Potassium homeostasis and renin–angiotensin–aldosterone system inhibitors. Clin J Am Soc Nephrol 2010;5:531–48
   PubMed Web of Science ®Google Scholar
• Crawford AH. Hyperkalemia: recognition and management of a critical electrolyte disturbance. J Infus Nurs 2014;37:167–75
   PubMedGoogle Scholar
• Hayes J, Kalantar-Zadeh K, Lu JL, et al. Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race. Nephron Clin Pract 2012;120:c8–16
   PubMedGoogle Scholar
• Mushiyakh Y, Dangaria H, Qavi S, et al. Treatment and pathogenesis of acute hyperkalemia. J Community Hosp Intern Med Perspect 2012;1:4
   Google Scholar
• Lehnhardt A, Kemper MJ. Pathogenesis, diagnosis and management of hyperkalemia. Pediatr Nephrol 2011;26:377–84
   PubMed Web of Science ®Google Scholar
• Luo JBS, Jensen DE, Yang A. Association between serum potassium and outcomes in patients with reduced kidney function. Clin J Am Soc Nephrol 2016;11:90–100
   PubMed Web of Science ®Google Scholar
• Greenlee M, Wingo CS, McDonough AA, et al. Narrative review: evolving concepts in potassium homeostasis and hypokalemia. Ann Intern Med 2009;150:619–25
   PubMed Web of Science ®Google Scholar
• Atlas SA. The renin–angiotensin–aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 2007;13(8SupplB):9–20
   Web of Science ®Google Scholar
• Allon M. Hyperkalemia in end-stage renal disease: mechanisms and management. J Am Soc Nephrol 1995;6:1134–42
   PubMed Web of Science ®Google Scholar
• Acker CG, Johnson JP, Palevsky PM, Greenberg A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998;158:917–24
   PubMed Web of Science ®Google Scholar
• Khanagavi J, Gupta T, Aronow WS, et al. Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes. Arch Med Sci 2014;10:251–7
   PubMed Web of Science ®Google Scholar
• Sarafidis PA, Georgianos PI, Bakris GL. Advances in treatment of hyperkalemia in chronic kidney disease. Expert Opin Pharmacother 2015;16:2205–15
   PubMed Web of Science ®Google Scholar
• Desai AS. Hyperkalemia in patients with heart failure: incidence, prevalence, and management. Curr Heart Fail Rep 2009;6:272–80
   PubMedGoogle Scholar
• Raebel MA, Ross C, Xu S, et al. Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med 2010;25:326–33
   PubMed Web of Science ®Google Scholar
• Noize P, Bagheri H, Durrieu G, et al. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals. Pharmacoepidemiol Drug Saf 2011;20:747–53
   PubMed Web of Science ®Google Scholar
• Betts KA, Woolley JM, Mu F, et al. Cost of Hyperkalemia in the United States. Kidney International Reports 2018. doi https://doi.org/10.1016/j.ekir.2017.11.003 [Last accessed February 2018]
   PubMed Web of Science ®Google Scholar
• Sarafidis P, Blacklock R, Wood E, et al. Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic. Clin J Am Soc Nephrol 2012;7:1234–41
   PubMed Web of Science ®Google Scholar
• Fleet J, Shariff S, Gandhi S, et al. Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission. BMJ Open 2012;2:e002011
   PubMed Web of Science ®Google Scholar
• Fitch K, Woolley J, Engel T, Blume H. Characterization of the burden of hyperkalemia in the Medicare population. Poster presented at the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting, San Francisco, CA, USA, 19–22 April 2016
   Google Scholar
• Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543–51
   PubMed Web of Science ®Google Scholar
• Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther 2012;30:e156–66
   PubMed Web of Science ®Google Scholar
• Annual Estimates of the Resident Population for Selected Age Groups by Sex for the United States, States, Counties, and Puerto Rico Commonwealth and Municipios: April 1, 2010 to July 1, 2014. Source: U.S. Census Bureau, Population Division. 2016. [Last accessed May 2016] https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkmk
   Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9.
   PubMed Web of Science ®Google Scholar
• Einhorn LM, Zhan M, Hsu VD, et al. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 2009;169:1156–62
   PubMed Web of Science ®Google Scholar
• Drawz P, Babineau D, Rahman M. Metabolic complications are common in elderly patients with chronic kidney disease. J Am Geriatr Soc 2012;60:310–15
   PubMed Web of Science ®Google Scholar
• Betts KA, Woolley JM, Mu F, et al. Development of a predictive model for hyperkalemia. American Society of Nephrology Kidney Week, 4 November 2017; Abstract nr 304
   Google Scholar
• Urbine T, Schwenke D, Wu W, Dev S. ICD9 coding of hyperkalemia greatly underestimates incidence of lab-defined hyperkalemia in veterans with heart failure. J Cardiac Failure 2013;19:S32
   Web of Science ®Google Scholar